<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.mlo-online.com/blog/news/55419534/stop-by-mlos-ascp-cap-acp-booth</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T16:48:33.000Z</news:publication_date><news:title>Stop by MLO’s ASCP/CAP-ACP booth! </news:title></news:news></url><url><loc>https://www.mlo-online.com/disease/infectious-disease/news/55419547/measles-resurgence-raises-stakes-for-laboratory-testing-and-surveillance</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T16:45:10.000Z</news:publication_date><news:title>Measles resurgence raises stakes for laboratory testing and surveillance</news:title></news:news></url><url><loc>https://www.mlo-online.com/diagnostics/news/55419542/roche-receives-fda-de-novo-authorization-for-cobas-pro-i-601-platform-with-ionify-gabapentin-assay</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T16:37:41.000Z</news:publication_date><news:title>Roche receives FDA De Novo authorization for cobas pro i 601 platform with Ionify Gabapentin assay</news:title></news:news></url></urlset>